| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAB | Common Stock | Purchase | $1.28M | +500K | +1.14% | $2.57 | 44.5M | May 15, 2024 | See footnote. | F1, F2 |
| transaction | LAB | Common Stock | Purchase | $1.27M | +500K | +1.12% | $2.54 | 45M | May 16, 2024 | See footnote. | F2, F3 |
| transaction | LAB | Common Stock | Purchase | $902K | +352K | +0.78% | $2.56 | 45.4M | May 17, 2024 | See footnote. | F2, F4 |
| holding | LAB | Common Stock | 13.9M | May 15, 2024 | See footnote. | F5 | |||||
| holding | LAB | Common Stock | 104K | May 15, 2024 | Direct | F6 | |||||
| holding | LAB | Common Stock | 2.74M | May 15, 2024 | See footnote. | F7 | |||||
| holding | LAB | Common Stock | 1.2M | May 15, 2024 | See footnote. | F8 | |||||
| holding | LAB | Common Stock | 7.55M | May 15, 2024 | See footnote. | F9 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $2.5473 to $2.58. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. |
| F2 | The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $2.5381 to $2.5429. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $2.5381 to $2.5798. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. |
| F5 | The securities are owned directly by Casdin Private Growth Equity Fund II, L.P. (the "Equity Fund II") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Equity Fund II, and (ii) Eli Casdin, the managing member of Casdin. |
| F6 | The securities are owned directly by Eli Casdin. |
| F7 | The securities are owned directly by Casdin Private Growth Equity Fund, L.P. (the "Equity Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Equity Fund, and (ii) Eli Casdin, the managing member of Casdin. |
| F8 | The securities are owned directly by Casdin Partners FO1-MSV, LP ("Casdin FO1") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to Casdin FO1, (ii) the GP, the general partner of Casdin FO1, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. |
| F9 | The securities are owned directly by CMLS Holdings II LLC ("CMLS Holdings II"). The Board of Managers of CMLS Holdings II includes Eli Casdin, who, as a member of the Board of Managers of CMLS Holdings II, shares voting and investment discretion with respect to the common stock held by CMLS Holdings II. |
Eli Casdin has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Casdin's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.